Self-reported initial management of childhood idiopathic thrombocytopenic purpura: Results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 2, 2003, Pages 130-133

  Vesely, Sara K ^a   Buchanan, George R ^b   Adix, Leah ^b   George, James N ^a   Cohen, Alan R ^c   Blanchette, Victor S ^d   Kühne, Thomas ^e  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Anti D; Idiopathic thrombocytopenic purpura; Intravenous gamma globulin; Pediatric hematology oncology; Purpura; Questionnaire; Thrombocytopenia

Indexed keywords

IMMUNOGLOBULIN; PREDNISONE; RHESUS D ANTIBODY;

ARTICLE; CHILD; CHILD HOSPITALIZATION; HEALTH SURVEY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; MUCOSAL BLEEDING; PETECHIA; PRIORITY JOURNAL; SELF REPORT; THROMBOCYTE COUNT;

ADULT; CHILD; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PREDNISONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUESTIONNAIRES; UNITED STATES;

EID: 0037320625     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200302000-00009     Document Type: Article

References (10)

1. Nugent DJ. Immune thrombocytopenic purpura: Why treat? J Pediatr 1999;134:3-4.
2. George JN. Initial management of immune thrombocytopenic purpura in children: Is supportive counseling without therapeutic intervention sufficient? J Pediatr 2000;137:598-600.
3. Medeiros D, Buchanan GR. Idiopathic thrombocytopenic purpura: beyond consensus. Curr Opin Pediatr 2000;12:4-9.
4. Bolton-Maggs PHB, Moon I. National audit of the management of childhood idiopathic thrombocytopenic purpura against UK guidelines: closing the loop: education and re-audit demonstrate a change in practice. Blood 2001;98:58b.
5. Eden OB, Lilleyman JS, British Paediatric Haematology Group. Guidelines for management of idiopathic thrombocytopenic purpura. Arch Dis Child 1997;67:1056-8.
6. Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol 1999;105:871-5.
7. Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 2000;137:629-32.
8. Vesely S, Buchanan GR, George JN. et al. A. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: Results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol 2000;22:55-61.
9. George JN, Woolf SH, Raskob et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology, Blood 1996;88:3-40.
10. Blanchette VS, Luke B, Andrew M, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989-95.